title: Antimycobacterial therapy in Crohn's disease: game over?
authors.forename: Laurent
authors.initials: L
authors.lastname: Peyrin-Biroulet
authors.forename: Christel
authors.initials: C
authors.lastname: Neut
authors.forename: Jean-Frédéric
authors.initials: JF
authors.lastname: Colombel
mesh_terms: D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017291:Clarithromycin / Q000627:therapeutic use; D002991:Clofazimine / Q000627:therapeutic use; D003424:Crohn Disease / Q000188:drug therapy* / Q000382:microbiology*; D004359:Drug Therapy, Combination; D006801:Humans; D009164:Mycobacterium Infections / Q000150:complications*; D009162:Mycobacterium avium / Q000145:classification*; D017828:Rifabutin / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D017828:Rifabutin; D002991:Clofazimine; D017291:Clarithromycin